Gumahad, Baby Girl .

HRN: 28-92-51  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/05/2026
AMPICILLIN 250MG (VIAL)
05/05/2026
05/11/2026
IVT
150mg
Q12H
PSNB (multiple Pustular Skin Lesions)
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  BloodstreamSkin & Soft Tissue    Compliance to guidelines: